First Time Loading...
F

Farmacosmo SpA
MIL:COSMO

Watchlist Manager
Farmacosmo SpA
MIL:COSMO
Watchlist
Price: 0.83 EUR -2.35% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

COSMO Price Targets Summary
Farmacosmo SpA

Wall Street analysts forecast COSMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COSMO is 1.43 EUR with a low forecast of 1.29 EUR and a high forecast of 1.6 EUR.

Lowest
Price Target
1.29 EUR
56% Upside
Average
Price Target
1.43 EUR
72% Upside
Highest
Price Target
1.6 EUR
92% Upside
Farmacosmo SpA Competitors:
Price Targets
BBW
Build-A-Bear Workshop Inc
33% Upside
4190
Jarir Marketing Company SJSC
27% Upside
ASO
Academy Sports and Outdoors Inc
36% Upside
SSG
Shaver Shop Group Ltd
16% Upside
8136
Sanrio Co Ltd
11% Upside
3028
Alpen Co Ltd
2% Upside
MUSTI
Musti Group Oyj
2% Upside
BELA
Jumbo SA
7% Upside

Revenue
Forecast

Revenue Estimate
Farmacosmo SpA

For the last 3 years the compound annual growth rate for Farmacosmo SpA's revenue is 17%. The projected CAGR for the next 2 years is 29%.

17%
Past Growth
29%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Farmacosmo SpA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Farmacosmo SpA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COSMO's stock price target?
Price Target
1.43 EUR

According to Wall Street analysts, the average 1-year price target for COSMO is 1.43 EUR with a low forecast of 1.29 EUR and a high forecast of 1.6 EUR.

What is Farmacosmo SpA's Revenue forecast?
Projected CAGR
29%

For the last 3 years the compound annual growth rate for Farmacosmo SpA's revenue is 17%. The projected CAGR for the next 2 years is 29%.